Abstract | PURPOSE: METHODS: This review was written on the basis of a computerized literature search of Medline. We considered all English language publications from 1966 to present using the following key words: methylphenidate, palliative care, and cancer. Forty-nine articles were identified as being relevant for this review. RESULTS: CONCLUSION: The medical literature supports the palliative use of methylphenidate in the care of patients with cancer. Further placebo-controlled trials are needed to elucidate the precise role that methylphenidate will have in providing symptom relief to dying patients.
|
Authors | Mark Rozans, Albert Dreisbach, Juan J L Lertora, Marc J Kahn |
Journal | Journal of clinical oncology : official journal of the American Society of Clinical Oncology
(J Clin Oncol)
Vol. 20
Issue 1
Pg. 335-9
(Jan 01 2002)
ISSN: 0732-183X [Print] United States |
PMID | 11773187
(Publication Type: Journal Article, Review)
|
Chemical References |
- Analgesics, Opioid
- Central Nervous System Stimulants
- Methylphenidate
|
Topics |
- Analgesics, Opioid
(adverse effects)
- Central Nervous System Stimulants
(therapeutic use)
- Cognition Disorders
(drug therapy, etiology)
- Depression
(drug therapy, etiology)
- Disorders of Excessive Somnolence
(chemically induced, drug therapy)
- Humans
- Methylphenidate
(therapeutic use)
- Neoplasms
(complications, drug therapy)
- Palliative Care
(methods)
|